loadpatents
Patent applications and USPTO patent grants for Menezes; Daniel.The latest application filed is for "antibody drug conjugates".
Patent | Date |
---|---|
Antibody drug conjugates Grant 10,626,172 - Abrams , et al. | 2020-04-21 |
Antibody Drug Conjugates App 20190194315 - ABRAMS; Tinya ;   et al. | 2019-06-27 |
Antibody Drug Conjugates App 20190119375 - Abrams; Tinya ;   et al. | 2019-04-25 |
Antibody drug conjugates Grant 10,005,836 - Abrams , et al. June 26, 2 | 2018-06-26 |
Antibody Drug Conjugates App 20160137730 - ABRAMS; Tinya ;   et al. | 2016-05-19 |
Treatment Of Melanoma App 20100086518 - Heise; Carla C. ;   et al. | 2010-04-08 |
Pi3 Kinase Inhibitors And Methods Of Their Use App 20100075965 - Ni; Zhi-Jie ;   et al. | 2010-03-25 |
Interleukin-2 muteins App 20060269515 - Denis-Mize; Kimberly ;   et al. | 2006-11-30 |
Methods for treating lymphomas App 20060251617 - Denis-Mize; Kimberly ;   et al. | 2006-11-09 |
NCAGE Code | 4EX94 | MENEZES DANIEL |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.